论文部分内容阅读
内容摘要:此报告为使用三种不同方法治疗毕夏氏病的比较结果分析,即环磷酰胺、激素、非激素抗炎因子。全部病人均观察最少一年以上。1.环磷酰胺治疗组临床反应:进步3例,轻度进步6例,不变12例,恶化3例,视力能长期保存。2.激素治疗组临床反应:进步“0”例,轻度进步仅1例,不变3例,恶化12例,视力在一年内迅速下降至0.1以下。3.非激素治疗组临床反应:进步“0”例,轻度进步2例,不变5例,恶化5例,治疗后视力缓慢下降。本文是环磷酰胺对毕夏氏病在目前说来是最有疗效的总结。
Abstract: This report analyzes the comparative results of three different methods of treatment of Psystrophia, namely cyclophosphamide, hormone, and non-hormonal anti-inflammatory factor. All patients were observed at least a year or more. Cyclophosphamide treatment group clinical response: progress in 3 cases, mild progress in 6 cases, unchanged in 12 cases, 3 cases of deterioration, visual acuity can be long-term preservation. 2. Clinical response to hormone therapy group: progress “0” cases, mild progress in only 1 case, unchanged in 3 cases, worsening in 12 cases, visual acuity rapidly decreased to 0.1 within a year. Clinical response in non-hormonal treatment group: Progressive “0” cases, mild progress in 2 cases, unchanged in 5 cases, worsening in 5 cases, after treatment, the visual acuity decreased slowly. This article is the conclusion that cyclophosphamide is the most potent for Psys.